Should we genetically test everyone for haemochromatosis?

Journal of Medical Ethics

Volumn 25, Issue 2, 1999, Pages 209-214

  Allen, Katrina ^a   Williamson, Robert ^a  

^a ROYAL CHILDREN'S HOSPITAL   (Australia)

Author keywords

Gene test; Genetic predictive testing; Haemochromatosis; Population screening

Indexed keywords

DNA;

GENETIC SCREENING; HEMOCHROMATOSIS; HIGH RISK POPULATION; HUMAN; MASS SCREENING; MEDICAL ETHICS; PREGNANCY TERMINATION; PRENATAL DIAGNOSIS; REVIEW;

EID: 0032928821     PISSN: 03066800     EISSN: None     Source Type: Journal    
DOI: 10.1136/jme.25.2.209     Document Type: Review

References (28)

1. Modell B, Moddell M. Towards a healthy baby: congenital disorders and the new genetics in primary health care. New York: Oxford University Press, 1992.
2. WHO scientific group report. Control of hereditary diseases. Geneva: WHO, 1996.
3. Burke W, Thomson E, Khoury M et al. Genetic testing for hereditary hemochromatosis and its implications. Journal of the American Medical Association 1998;280,2:172-7.
4. Williamson R. Universal community carrier screening for cystic fibrosis. Nature Genetics 1993;3:195-201.
5. DudokdeWit AC, Tibben A, Duivenvoorden HJ et al. Distress in individuals facing predictive DNA testing for autosomal dominant late-onset disorders: comparing questionnaire results with in-depth interviews. American Journal of Medical Genetics 1998; 75,1:62-74.
6. Morris MJ, Tyler A, Lazarou L et al. Problems in genetic prediction for Huntington's disease. Lancet 1982;2(8663):601-3.
7. Adams PC, Kersatz AE, Valberg LS. Clinical presentation of hemochromatosis. American Journal of Medicine 1991;90:445-9.
8. Powell LW. Hemochromatosis, the impact of early diagnosis and therapy. Gastroenterology 1996;110:1304-7.
9. Niederau C, Fischer R, Purschell A et al. Long-term survival in patients with hereditary haemochromatosis. Gastroenterology 1996;110:1107-1119.
10. Adams PC, Agnew S. Alcoholism in hereditary hemochromatosis revisited: prevalence and clinical consequences amongst homozygous siblings. Hepatology 1996;23:724-7.
11. Feder JN, Gnirke A, Thomas W et al. A novel MHC class I-like gene is mutated in patients with hereditary hemochromatosis. Nature Genetics 1996;13:399-408.
12. Jouanolle AM, Fergelot P, Gandon G et al. A candidate gene for hemochromatosis: frequency of the C282Y and H63D mutations. Human Genetics 1997;100:544-7.
13. Jazwinska EC, Cullen LM, Busfield F et al. Haemochromatosis and HFE. Nature Genetics 1996;13:399-408.
14. The UK Haemochromatosis Consortium. A simple genetic test identifies 90% of UK patients with haemochromatosis. Gut 1997;41,6:841-4.
15. Legget BA, Halliday JW, Brown NN et al. Prevalence of haemochromatosis amongst asymptomatic Australians. British Journal of Haematology 1990;74:525-30.
16. Powell LM, Bassett ML. Haemochromaotisis: diagnosis and management after the cloning of the HFE gene. Australian and New Zealand Journal of Medicine 1998;28:159-63.
17. Burke W, Press N, McDonell SM. Hemochromatosis: genetics helps to define a multifactorial disease. Clinical Genetics 1998;54:1-9.
18. Crawford HG, Jazwinska EC, Cullen LM et al. Expression of HLA-linked hemochromatosis in subjects homozygous or heterozygous for the C282Y mutation. Gastroenterology 1998;114: 1003-8.
19. Bulaj ZJ, Griffen LM, Jorde LB et al. Clinical and biochemical abnormalities in people heterozygous for hemochromatosis. New England Journal of Medicine 1996;335:1799-1805.
20. George DK, Goldwurm S, MacDonald GA et al. Increased hepatic iron concentration in nonalcoholic steatohepatitis is associated with increased fibrosis. Gastroenterology 1998;114: 311-18.
21. Bassett ML, Leggett BA, Halliday JW et al. Analysis of the cost of population screening for haemochromatosis using biochemical and genetic markers. Journal of Hepatology 1997;27:517-24.
22. Carter R, Glasziou P, van Oortmarssen G et al. Cost-effectiveness of mammographic screening in Australia. Australian Journal of Public Health 1993;17,1:42-50.
23. Bacon BR. Diagnosis and management of haemochromatosis. Gastroenterology 1997;113: 995-9.
24. Lench N, Stanier P, Williamson R. Simple non-invasive method to obtain DNA for gene analysis. Lancet 1988;1:1356-8.
25. Bekendorf JL, Reutenauer JE, Hughes CA et al. Patients' attitudes about autonomy and confidentiality in genetic testing for breast-ovarian cancer susceptibility. American Journal of Medical Genetics 1997;73:296-303.
26. Otlowski M, Chalmers D, Skene L et al. Discussion paper. Implications of the human genome project for Australian insurance law and practice. Canberra: Australian Research Council, 1998.
27. Hudson KL, Rothenberg KH, Andrews LB et al. Genetic discrimination and health insurance: an urgent need for reform. Science 1995;270:391-3.
28. Piperno A, Sampietro M, Pietrangelo A et al. Heterogeneity of hemochromatosis in Italy. Gastroenterology 1998;114:996-1002.